Gyrolab Immunoassays: Miniaturization, Automation, and Integration into a Rapid Workflow

Area of Science:

• Biotechnology
• Analytical Chemistry
• Immunology

Background:

• Gyrolab is an automated immunoassay platform utilizing microfluidic disc technology.
• It generates column profiles to analyze biomolecular interactions and quantify analytes.
• The platform supports a wide range of applications, including biomarker monitoring and biopharmaceutical development.

Purpose of the Study:

• To provide an overview of Gyrolab technology, its components, and assay development workflow.
• To illustrate the application of Gyrolab immunoassays through case studies.
• To highlight the utility of Gyrolab in therapeutic antibody and biomarker quantification.

Main Methods:

• Overview of Gyrolab system components and assay development process.
• Selection of affinity reagents and Gyrolab Bioaffy CDs.
• Optimization of assay conditions for immunoassays.
• Case studies involving pembrolizumab pharmacokinetics and interleukin-2 quantification.

Main Results:

• Demonstrated the ability to generate pharmacokinetic data for pembrolizumab.
• Successfully quantified interleukin-2 in human serum and buffer.
• Showcased the platform's versatility across different matrices and concentration ranges.

Conclusions:

• Gyrolab technology offers a robust and versatile solution for immunoassay automation.
• The platform is suitable for diverse applications in biopharmaceutical research and clinical monitoring.
• Case studies validate its efficacy in quantifying therapeutic antibodies and biomarkers like IL-2.